Identifying responders to acid suppression in dyspepsia using a random starting day trial
暂无分享,去创建一个
O. Bonnevie | P. Funch‐jensen | O. B. Schaffalitzky de Muckadell | P. Bytzer | S. Rune | J. Hansen | H. Breinstrup | P. Matzen | V. Meineche-Schmidt
[1] P. Bytzer,et al. H2 receptor antagonists and prokinetics in dyspepsia: a critical review , 2002, Gut.
[2] J. Hansen,et al. Value of the unaided clinical diagnosis in dyspeptic patients in primary care , 2001, American Journal of Gastroenterology.
[3] M. Camilleri,et al. Functional gastroduodenal disorders , 1999, Gut.
[4] Talley,et al. Efficacy of omeprazole in functional dyspepsia: double‐blind, randomized, placebo‐controlled trials (the Bond and Opera studies) , 1998, Alimentary pharmacology & therapeutics.
[5] I. Wiklund,et al. Does endoscopy have a positive impact on quality of life in dyspepsia? , 1998, Gastrointestinal endoscopy.
[6] M. Osnes,et al. Ranitidine effectively relieves symptoms in a subset of patients with functional dyspepsia. , 1997, Scandinavian journal of gastroenterology.
[7] G. Barbara,et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. , 1996, Gastroenterology.
[8] P. Farup,et al. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine? , 1995, Scandinavian journal of gastroenterology.
[9] M. Fennerty. Empirical H2 blocker therapy or prompt endoscopy in the management of dyspepsia. , 1995, Gastrointestinal endoscopy.
[10] Ø. Hovde,et al. Mesalazine suppositories versus hydrocortisone foam in patients with distal ulcerative colitis. A comparison of the efficacy and practicality of two topical treatment regimens. , 1995, Scandinavian journal of gastroenterology.
[11] L. Melton,et al. Onset and disappearance of gastrointestinal symptoms and functional gastrointestinal disorders. , 1992, American journal of epidemiology.
[12] S. Larsen,et al. Ranitidine for non-ulcer dyspepsia. A clinical study of the symptomatic effect of ranitidine and a classification and characterization of the responders to treatment. , 1991, Scandinavian journal of gastroenterology.
[13] O. Flaten,et al. The multi-crossover model for classifying patients as responders to a given treatment. , 1991, Scandinavian journal of gastroenterology.
[14] O. B. Schaffalitzky de Muckadell,et al. Efficacy and outcome of an open access endoscopy service. , 1991, Danish medical bulletin.
[15] P. Knipschild,et al. Looking for gall bladder disease in the patient's iris. , 1988, BMJ.
[16] T. Halvorsen,et al. Cimetidine responders in non-ulcer dyspepsia. , 1988, Scandinavian journal of gastroenterology.
[17] R. Torp,et al. Patients with functional dyspepsia responding to omeprazole have a characteristic gastro-oesophageal reflux pattern. , 1999, Scandinavian journal of gastroenterology.
[18] O. B. Schaffalitzky de Muckadell,et al. Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping. , 1998, Scandinavian journal of gastroenterology.
[19] H. Petersen,et al. Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials. , 1992, Scandinavian journal of gastroenterology.
[20] L. Sandvik,et al. The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model. , 1985, Scandinavian journal of gastroenterology.